CLINICAL_TRIALS
trial_result
· 2019-05-07
Clinical Trial Update: Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata [Phase 2]
Summary
A Phase 2 pilot study investigated the efficacy of ruxolitinib for alopecia areata; results have been posted following completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07